| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 96.0 % |
| Melting Point | 226-229°C |

N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]propyl]tetrahydro-2-furancarboxamide Hydrochloride
4-Amino-6,7-dimethoxy-2-[methyl[3-[(tetrahydro-2-furoyl)amino]propyl]amino]quinazoline Hydrochloride
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C19H27N5O4·HCl = 425.91 |
| Physical State (20 deg.C) | Solid |
| CAS RN | 81403-68-1 |
| Unit | Price |
| 100 mg | 4950 |
| 500 mg | 7950 |
| 1 g | 11975 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 96.0 % |
| Melting Point | 226-229°C |
| Note | • Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. |
|---|